{{Drugbox
| IUPAC_name = 8-[(2-hydroxyethyl)(methyl)amino]-1,3,7-trimethyl-3,7-dihydro-1''H''-purine-2,6-dione
| image = Cafaminol.png
| width = 250px
| alt = Skeletal formula of cafaminol
| image2 = Cafaminol 3D ball.png
| width2 = 225px
| alt2 = Ball-and-stick model of the cafaminol molecule

<!--Clinical data-->
| tradename = Rhinetten, Rhinoptil
| pregnancy_category = 
| legal_status = Rx-only
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number = 30924-31-3
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 35685
| ChemSpiderID = 32824
| ChEMBL = 2104570
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0L1S25NC1L
| synonyms = Methylcoffanolamine; 8-(2-Hydroxyethyl)methylaminocaffeine

<!--Chemical data-->
| C=11 | H=17 | N=5 | O=3 
| molecular_weight = 267.28 g/mol
| SMILES = O=C2N(c1nc(n(c1C(=O)N2C)C)N(CCO)C)C
| StdInChI = 1S/C11H17N5O3/c1-13(5-6-17)10-12-8-7(14(10)2)9(18)16(4)11(19)15(8)3/h17H,5-6H2,1-4H3
| StdInChIKey = ZGNRRVAPHPANFI-UHFFFAOYSA-N
}}

'''Cafaminol''' (brand names '''Rhinetten''', '''Rhinoptil'''), also known as '''methylcoffanolamine''', is a [[vasoconstrictor]] and [[anticatarrhal]] of the [[methylxanthine]] family related to [[caffeine]] which is used as a [[nasal decongestant]] in [[Germany]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA205|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=205–}}</ref><ref name="IndexNominum2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA157|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=157–}}</ref><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA784|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=784–}}</ref><ref name="pmid5818666">{{cite journal | vauthors = Szirmai E | title = [A new treatment for colds using a new caffeine derivative, methylcoffanolamine] | language = German | journal = Praxis | volume = 58 | issue = 13 | pages = 412–4 | year = 1969 | pmid = 5818666 | doi = | url = }}</ref><ref name="pmid515164">{{cite journal | vauthors = Walther H, Köhler E | title = [Human pharmacologic studies on the biologic availability and resorption of cafaminol (AWD) (proceedings)] | language = German | journal = Pharmazie | volume = 34 | issue = 5-6 | pages = 375–6 | year = 1979 | pmid = 515164 | doi = | url = }}</ref><ref name="pmid3913153">{{cite journal | vauthors = Rogowski M, Chodynicki S | title = [Use of the preparation Cafaminol in the treatment of acute rhinitis] | language = Polish | journal = Wiad. Lek. | volume = 38 | issue = 20 | pages = 1437–40 | year = 1985 | pmid = 3913153 | doi = | url = }}</ref> It was introduced in 1974 and was still in use as of 2000.<ref name="Publishing2013" /><ref name="IndexNominum2000 />

==References==
{{Reflist|2}}


{{Decongestants}}

[[Category:Decongestants]]
[[Category:Vasoconstrictors]]
[[Category:Xanthines]]